Results 271 to 280 of about 120,252 (303)
Some of the next articles are maybe not open access.
Invasive fungal infections in pediatric oncology
Pediatric Blood & Cancer, 2011AbstractBackgroundData on the epidemiology and outcome of invasive fungal infections in children with cancer are limited. The aim of the study was to delineate the epidemiologic, clinical features, risk factors, and outcome of invasive fungal infections in this population.ProcedureThe medical records of all children with malignancies diagnosed with an ...
Meirav, Mor +5 more
openaire +2 more sources
Tailored Treatment of Invasive Fungal Infections
Future Microbiology, 2008The need to tailor antifungal treatment to local epidemiology and individual patient risk was a key theme of the 3rd Trends in Medical Mycology (TIMM-3) congress in Turin, Italy, 28–31 October 2007. Organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organisation for Research and ...
Johan, Maertens, Jenny, Bryan
openaire +2 more sources
Pediatric Invasive Fungal Infections
2018Invasive fungal infections are increasing in incidence and constitute an important cause for morbidity and mortality in immunocompromised pediatric patient populations, including but not limited to preterm neonates, critically ill children and adolescents in the intensive care unit and those with hematological malignancies or undergoing hematopoietic ...
Andreas Groll +2 more
openaire +1 more source
The Challenge of Invasive Fungal Infection
Chemotherapy, 1999Systemic fungal infections cause almost 25% of the infection-related deaths in leukaemic patients. Particularly those with prolonged neutropenia are at risk but mycoses also feature in critically ill intensive care patients and in individuals who are treated for solid tumours and AIDS, or who received an organ transplant.
B E, de Pauw, F, Meunier
openaire +2 more sources
New approaches to invasive fungal infections
Current Opinion in Hematology, 2003Invasive fungal infections are typically difficult to prevent, diagnose, and treat; consequently, fungal infection-related mortality has become high, particularly among patients with prolonged neutropenia and severe graft-versus-host disease. However, much recent progress has been made in understanding the immune response to fungi and the epidemiology ...
openaire +2 more sources
Treatment Options for Invasive Fungal Infections
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006Clinicians face an increasing occurrence of invasive fungal infections. These are due not only to traditional yeast and mould species but also to rare pathogens that can be difficult to treat. The introduction of new agents has expanded the options for treating common and rare mycotic infections with antifungal efficacy at least equal, and safety far ...
openaire +2 more sources
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
Ca-A Cancer Journal for Clinicians, 2021Amila K Nanayakkara +2 more
exaly
Biomaterial-based antimicrobial therapies for the treatment of bacterial infections
Nature Reviews Materials, 2021Pranav P Kalelkar +2 more
exaly
Invasive Fungal Infections in Children
Pediatric Infectious Disease Journal, 2009Hans Jürgen, Dornbusch +4 more
openaire +2 more sources